Minocycline-induced Hyperpigmentation Confined to Lupus Miliaris Disseminatus Faciei
Acta Derm Venereol. 2023 Dec 7;103:adv18462. doi: 10.2340/actadv.v103.18462.NO ABSTRACTPMID:38059580 | DOI:10.2340/actadv.v103.18462 (Source: Acta Derm Venereol A...)
Source: Acta Derm Venereol A... - December 7, 2023 Category: Dermatology Authors: Masakazu Kakurai Rie Honda Hanako Miyahara Shusaku Ito Source Type: research
Minocycline-induced Hyperpigmentation Confined to Lupus Miliaris Disseminatus Faciei
Acta Derm Venereol. 2023 Dec 7;103:adv18462. doi: 10.2340/actadv.v103.18462.NO ABSTRACTPMID:38059580 | DOI:10.2340/actadv.v103.18462 (Source: Acta Dermato-Venereologica)
Source: Acta Dermato-Venereologica - December 7, 2023 Category: Dermatology Authors: Masakazu Kakurai Rie Honda Hanako Miyahara Shusaku Ito Source Type: research
An update on combination therapies for multiple sclerosis: where are we now?
Expert Rev Neurother. 2023 Dec 6:1-15. doi: 10.1080/14737175.2023.2289572. Online ahead of print.ABSTRACTINTRODUCTION: In theory, combination of two agents, which are suboptimal when given individually, may result in a significant increase in therapeutic effect. Combination therapies have proven particularly effective against infections such as HIV, cancer, and also chronic autoimmune diseases such as rheumatoid arthritis.AREAS COVERED: The authors review the literature, searching for randomized placebo-controlled or comparative, double-blind or investigator-blinded clinical trials, not including open label clinical trials...
Source: Expert Review of Neurotherapeutics - December 7, 2023 Category: Neurology Authors: Per Soelberg Sorensen Melinda Magyari Finn Sellebjerg Source Type: research
